| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Bellevue Life Sciences Acquisition Corp.
13G/A
BLAC · 079174108
|
87.7% |
2/11/2025
Event 12/31/2024
|
||||
| Bellevue Global Life Science Investors, LLC | 58.4% | |||||
| BCM Europe AG | 29.3% | |||||
| Bellevue Capital Management LLC | 87.7% | |||||
| Kuk Hyoun Hwang | 87.7% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.